These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25423769)

  • 21. Maxim and Roche collaborate for development of hepatitis C drug.
    AIDS Read; 2000 Sep; 10(9):545. PubMed ID: 11019452
    [No Abstract]   [Full Text] [Related]  

  • 22. Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients.
    Reesink HW; Fanning GC; Farha KA; Weegink C; Van Vliet A; Van 't Klooster G; Lenz O; Aharchi F; Mariën K; Van Remoortere P; de Kock H; Broeckaert F; Meyvisch P; Van Beirendonck E; Simmen K; Verloes R
    Gastroenterology; 2010 Mar; 138(3):913-21. PubMed ID: 19852962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C and the 'cure'.
    Cooksley WG
    Aust Fam Physician; 1998 Dec; 27(12):1086. PubMed ID: 9919728
    [No Abstract]   [Full Text] [Related]  

  • 24. Anemia during treatment of hepatitis C in HIV-infected patients.
    Lo Re V; Kostman JR
    AIDS Read; 2004 Oct; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent progress in the treatment of interferon-resistant hepatitis C].
    Kumada M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1759-62. PubMed ID: 10581760
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy of interferon combined glycyrrhizin therapy in patients with interferon-resistant chronic hepatitis C].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1022-5. PubMed ID: 7563661
    [No Abstract]   [Full Text] [Related]  

  • 27. [When and how should hepatitis C be treated?].
    Färkkilä M
    Duodecim; 2010; 126(1):41-8. PubMed ID: 20405608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)].
    Juszczyk J; Bolewska B; Flieger J; Swietek K; Adamek B; Biskupska-Karasińska M; Dziambor AP; Boroń-Kaczmarska A; Wawrzynowicz-Syczewska M; Cianciara J; Kozłowska J; Daniluk J; Słomka M; Dudziak M; Zaborowski P; Gładysz A; Piszko P; Gonciarz Z; Mazur W; Machniak M; Kryczka W; Zarebska-Michaluk D; Trocha H; Witczak-Malinowska K; Lakomy E; Kuydowicz J; Niwicka-Michałowska A
    Pol Merkur Lekarski; 2001 Oct; 11(64):340-3. PubMed ID: 11770315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial comment: triple infection with HIV and hepatitis B and C viruses--lesson in combination therapy.
    Dore GJ
    AIDS Read; 2004 Jul; 14(7):392. PubMed ID: 15282869
    [No Abstract]   [Full Text] [Related]  

  • 30. On the cusp of change: new therapeutic modalities for HCV.
    Rodríguez-Torres M
    Ann Hepatol; 2010; 9 Suppl():123-31. PubMed ID: 20714009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New hepatitis C therapies.
    Pawlotsky JM
    Semin Liver Dis; 2014 Feb; 34(1):7-8. PubMed ID: 24782253
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drugs for hepatitis B and C infection].
    Iino S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():391-5. PubMed ID: 17455651
    [No Abstract]   [Full Text] [Related]  

  • 33. HCV compound in trials.
    AIDS Patient Care STDS; 2000 May; 14(5):285-6. PubMed ID: 10833820
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis C in 2012.
    Lemon M
    S D Med; 2012 Nov; 65(11):432-3. PubMed ID: 23189411
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of hepatitis C with new direct antiviral drugs: towards a disease cure].
    Halfon P; Cacoub P
    Rev Med Interne; 2014 Apr; 35(4):219-21. PubMed ID: 24559772
    [No Abstract]   [Full Text] [Related]  

  • 36. Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C.
    Fabris P; Tositti G; Giordani MT; Infantolino D; de LF
    Am J Gastroenterol; 2002 Feb; 97(2):492-3. PubMed ID: 11866300
    [No Abstract]   [Full Text] [Related]  

  • 37. [Coinfection of hepatitis C virus and human immunodeficiency virus and antiretroviral multitherapies].
    Zylberberg H; Pol S
    Gastroenterol Clin Biol; 1999; 23(8-9):878-81. PubMed ID: 10533139
    [No Abstract]   [Full Text] [Related]  

  • 38. Retreatment of hepatitis C patients who do not respond to interferon: the search continues.
    Pianko S; McHutchison J
    Am J Gastroenterol; 2000 May; 95(5):1122-4. PubMed ID: 10811315
    [No Abstract]   [Full Text] [Related]  

  • 39. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
    Husa P
    J Gastroenterol Hepatol; 2005 May; 20(5):669-70. PubMed ID: 15853976
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.